Drug considered therapeutic ‘game changer’ of once lethal disease BOSTON UNIVERSITY SCHOOL OF MEDICINE (Boston)–There’s a new treatment option available for patients with AL amyloidosis: daratumumab. Studied in a prospective clinical trial, only one of the two clinical trials of this agent in AL amyloidosis worldwide, researchers have found this anti-cancer drug to be well...